At ChemCon, we are thrilled to announce an ambitious expansion of our production facility. As a Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs), this enhancement is part of our continuous commitment to innovation and excellence. With a recent investment of €6 million ($7 million), this effort complements the €10 million ($11 million) we have already dedicated to developing and modernizing our facilities in recent years.
Our expansion is in direct response to the growing demand for polymers, particularly Polyethylenimines (PEI) and Polyoxazolines (POx), which are increasingly vital in the pharmaceutical sector. With over 15 years of expertise in producing PEI and POx under Good Manufacturing Practice (GMP) conditions, we are proud to be among the select few CDMOs globally equipped for this task.
A key feature of our facility's expansion is the enhancement of our Research & Development (R&D) laboratories, now equipped with the latest technological advancements. The centerpiece of these upgrades is our new, largest cleanroom, boasting an ISO 8 D classification. Designed to not only meet but exceed the stringent requirements of GMP regulations, this cleanroom has been inspected by local authorities and will start production right away.
By expanding our facilities and investing in cutting-edge technology, we at ChemCon are not merely preparing for the future; we are actively defining it. Our improved research and development capabilities, coupled with the integration of our advanced cleanroom, position us at the forefront of meeting the dynamic needs of the pharmaceutical sector. This advancement ensures our ability to provide a consistent, high-quality supply of GMP-compliant polymers and inorganic salts, underlining our dedication to excellence and reliability in serving the healthcare industry.
This expansion signifies our ongoing commitment to excellence in pharmaceutical manufacturing, research, and development. We continue to strengthen our position as a trusted partner in the pharmaceutical industry, dedicated to quality, reliability, and innovation.
You can also explore our new fourth floor for yourself with our virtual tour.
